In preclinical experiments in implanted breast cancer tumors in mice, glucosamine (GlcN) exhibited enhanced chemical exchange saturation transfer (CEST) MRI signals. Moving toward clinical application, considering the excellent safety profile of GlcN, we examined the feasibility of using the GlcN CEST method to detect human breast cancer on a 3T clinical scanner. Here we report significant CEST MRI signals resulting from the exchangeable protons of GlcN hydroxyls, amine/amide residues as well as nuclear Overhauser enhancement (NOE). Thus, CEST MRI using GlcN has the potential to detect tumors and report their activity, without the use of a gadolinium contrast agent.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords